JW Shinyak, a Kosdaq-listed biotech company, said Wednesday that it has started selling Ducray Neoptide Expert, Pierre Fabre’s hair loss relief cosmetic.

Ducray Neoptide Expert is a specialized cosmetic for hair loss relief developed through clinical trials and is available at medical institutes for hair loss treatment nationwide, including dermatology clinics.

According to JW Shinyak, the product reduces the synthesis of the male hormone dihydrotestosterone (DHT), which is the main cause of hair loss, by 59.6 percent and increases the growth period of hair by 23 percent, increasing hair retention.

Ducray Neoptide Expert contains ingredients such as silybum marianum, also known as milk thistle, and lespedeza capitata, which are effective in strengthening hair fiber and preventing hair loss.

In addition, the product is easy to use with its spray-type cap, and it can be used not only for hair transplant patients but also for patients who are using existing hair loss treatments such as minoxidil and finasteride.

Pierre Fabre is a French pharmaceutical company that introduced the concept of dermocosmetics, which combines skin treatment and beauty and has more than 10 brands, including Ducray, Avene, and Aderma.

With the launch of Ducray Neoptide Expert, JW Shinyak has expanded its hair loss care lineup by entering the hair loss dermocosmetics market, following its Finasteride and Dutasteride series of hair loss treatments.

"Based on our sales and marketing competitiveness in the domestic clinic market, we have expanded our sales area to hair loss relief cosmetics," a JW Shinyak official said. "We will continue to expand our hair loss care lineup to provide various treatment options for patients who are worried about the stress of hair loss."